NYX‐2925, A Novel N‐methyl‐D‐aspartate Receptor Modulator: A First‐in‐Human, Randomized, Double‐blind Study of Safety and Pharmacokinetics in Adults

por Houck, David R., Sindelar, Laurel, Sanabria, Carlos R., Stanworth, Stephanie H., Krueger, Maggie, Suh, Mary, Madsen, Torsten M.
Publicado 2018

NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory

por Khan, M Amin, Houck, David R, Gross, Amanda L, Zhang, Xiao-lei, Cearley, Cassia, Madsen, Torsten M, Kroes, Roger A, Stanton, Patric K, Burgdorf, Jeffrey, Moskal, Joseph R
Publicado 2017